Methods for the treatment of neuroleptic and related disorders using sertindole derivatives
US6489341B1 · kind B1 · utility
29Cited by
8References
37Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 30, 2000 |
| Grant date | Dec 3, 2002 |
| Priority date | — |
| Expiry date | May 30, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods of administering pharmaceutical compositions and dosage forms comprising the sertindole derivatives nor-sertindole, 5-oxo-sertindole, dehydro-sertindole, and dehydro-nor-sertindol. The methods of the invention are directed to the treatment and prevention of neuroleptic and related disorders such as, psychotic disorders, depression, anxiety, substance addiction, memory impairment and pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.